2 Questions 1 Answers 0 Followers
Questions related from Lijing Guo
Is there a preferred method for oncology trials?
13 May 2014 7,271 1 View
I am interested in seeing how they will shift the AD landscape and whether they are considered disease modifying.
15 April 2014 130 2 View